Skip to content

DETHOSOL

Active Risk: not assessed
Private limited companyfounded 2023active for 3 yearsLangemuntstraat 29, 9240 Zele, BelgiumKBO/BCE: BE 0803.190.880
Summary

DETHOSOL is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €19,308 and a net result of €5,027. Equity is growing by about 36% per year across the filed financial years. Its solvency ranks better than 43% of 9,767 sector peers (NACE 64, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

History

DETHOSOL was incorporated on 26 June 2023 as a private limited company.1 The registered office was moved to Zele in 2026.2 Total assets fell from €61,962 in 2023 to €45,331 in 2025.3

  1. 1KBO (Crossroads Bank for Enterprises)
  2. 2Belgian Official Gazette, 06-01-2026
  3. 3National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
13-03
NBB filing Annual accounts filed
financial year 2025 · micro format
06-01
Gazette deed Registered office
Registered-office move4 facts ▸
  • Board meeting, 24-11-2025
  • Registered-office move, Langemuntstraat 29 te 9240 Zele
  • General meeting, “éénparigheid van stemmen, publicatie van deze beslissingen” (deed in Dutch)
  • Other statement, “publicatienummer, *26002312*” (deed in Dutch)
2025
14-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Highest result from 2023 to 2025net €5,362 ▲36.8%
Operating result €8,432, net result €5,362, both a record.
03-07
NBB filing Annual accounts filed
financial year 2023 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette acts we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.